EUVIMEDEUVIMED entdecken
Open Access

β-Hydroxybutyrate attenuates bronchial smooth muscle proinflammatory cytokine production and contraction

V Amanda Fastiggi, Madeleine M Mank, Matthew A Caporizzo iD, Matthew E Poynter iD

American Journal of Physiology-Cell Physiology · 01.06.2026 · 330 (6) · C1561-C1573

DOI: 10.1152/ajpcell.00169.2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.06.2026. Verfasst von V Amanda Fastiggi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Disease and Critical Care, Department of Medicine, The Vermont Lung Center, University of Vermont, Burlington, Vermont, United …. Hauptthemen laut MEDLINE: 3-Hydroxybutyric Acid, Bronchi, Cytokines, Muscle, Smooth. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Vermont Space Grant Consortium (VTSGC), NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma is characterized by airway inflammation and bronchoconstriction, with aberrant bronchial smooth muscle function contributing to disease severity. Therapeutic ketosis, achieved through a ketogenic diet or exogenous ketone supplementation, attenuates airway inflammation and bronchial hyperresponsiveness. Using bronchial smooth muscle cells and precision-cut lung slices, we demonstrate that the ketone body β-hydroxybutyrate (BHB) suppresses IL-1β-induced proinflammatory cytokine production and histamine-evoked bronchoconstriction via activation of the free fatty acid receptor FFAR3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

3-Hydroxybutyric AcidBronchiCytokinesMuscle, SmoothMuscle ContractionAsthmaMyocytes, Smooth MuscleInflammation MediatorsAnimalsHumansMiceBronchoconstrictionMice, Inbred C57BLMaleInterleukin-1betaInflammation

Stichwörter der Autor:innen

asthmabronchial smooth musclebronchoconstrictioninflammationβ-hydroxybutyrate

Substanzen

3-Hydroxybutyric AcidCytokinesInflammation MediatorsInterleukin-1beta

Autor:innen und Institutionen

  • Division of Pulmonary Disease and Critical Care, Department of Medicine, The Vermont Lung Center, University of Vermont, Burlington, Vermont, United States.
  • Cellular, Molecular, and Biomedical Sciences Doctoral Program, University of Vermont, Burlington, Vermont, United States.
  • Department of Molecular Physiology and Biophysics, University of Vermont, Burlington, Vermont, United States.

ORCID-Profile: Matthew A Caporizzo, Matthew E Poynter

Förderung

  • NIGMS NIH HHS
  • Vermont Space Grant Consortium (VTSGC)
  • NHLBI NIH HHS
  • USDA | Agricultural Research Service (ARS)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • UVM | LCOM | Cardiovascular Research Institute of Vermont, Larner College of Medicine, University of Vermont (CVRI)
  • U.S. Department of Education (ED)

Zitieren

APA

Fastiggi, V. A., Mank, M. M., Caporizzo, M. A., & Poynter, M. E. (2026). β-Hydroxybutyrate attenuates bronchial smooth muscle proinflammatory cytokine production and contraction. American Journal of Physiology-Cell Physiology, 330(6), C1561-C1573. https://doi.org/10.1152/ajpcell.00169.2026

Vancouver

Fastiggi VA, Mank MM, Caporizzo MA, Poynter ME. β-Hydroxybutyrate attenuates bronchial smooth muscle proinflammatory cytokine production and contraction. American Journal of Physiology-Cell Physiology. 2026;330(6):C1561-C1573. doi:10.1152/ajpcell.00169.2026

BibTeX
@article{Fastiggi2026,
  author = {Fastiggi, V Amanda and Mank, Madeleine M and Caporizzo, Matthew A and Poynter, Matthew E},
  title = {β-Hydroxybutyrate attenuates bronchial smooth muscle proinflammatory cytokine production and contraction},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2026},
  volume = {330},
  number = {6},
  pages = {C1561--C1573},
  doi = {10.1152/ajpcell.00169.2026}
}
Kostenlos starten →